Topical application of integrin antagonists inhibits proliferative retinopathy

Hormone and Metabolic Research

Volumn 33, Issue 5, 2001, Pages 307-311

  Riecke, B ^a   Chavakis, E ^a   Bretzel, R G ^a   Linn, T ^a   Preissner, K T ^a   Brownlee, M ^b   Hammes, H P ^a,c  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

v type integrins; Angiogenesis; Diabetic retinopathy; RGD peptides

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BENZALKONIUM CHLORIDE; EDETIC ACID; INTEGRIN; MANNITOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; DOSE RESPONSE; DRUG INHIBITION; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA NEOVASCULARIZATION;

ADHESIVENESS; ADMINISTRATION, TOPICAL; ANIMALS; ANOXIA; DIABETIC RETINOPATHY; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; OLIGOPEPTIDES; OPHTHALMIC SOLUTIONS; RECEPTORS, VITRONECTIN; RETINA;

ANIMALIA;

EID: 0034956835     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-15279     Document Type: Article

References (31)

1. The cellular and molecular mechanisms of diabetic complications
2. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study
3. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study
4. Global data on blindness
5. Association of ocular disease and mortality in a diabetic population
6. Retinopathy predicts coronary heart disease events in NIDDM patients
7. Treatment of diabetic retinopathy
8. Diabetic retinopathy
9. The role of alpha v integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
10. Requirement of vascular integtin vß3 for angiogenesis
11. Involvement of integrin v gene expression in human melanoma tumorigenicity
12. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
13. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
14. Oxygen-induced retinopathy in the mouse
15. Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization
16. Antagonists of integrin alpha v beta 3 inhibit retinal neovascularization in a murine model
17. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases
18. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox
19. Definition of two angiogenic pathways by distinct alpha v integrins
20. Kinetic analysis of integrin-dependent cell adhesion on vitronectin-the inhibitory potential of plasminogen activator inhibitor-1 and RGD peptides
21. Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1
22. Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins
23. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
24. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy
25. Essential role of growth hormone in ischemia-induced retinal neovascularization
26. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
27. Octreotide reduces the risk for vitreous hemorrhages and loss of visual acuity in patients with high risk poliferative diabetic retinopathy
28. Dramatic inhibition of retinal and choroidal neovascularization by oral administration of a kinase inhibitor
29. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization
30. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy
31. Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins